Sativex is the only regulatory-
approved cannabinoid treatment
for patients with MS spasticity1,2

Sativex is an
oromucosal spray
containing a complex
botanical mixture
derived from the
Cannabis
sativa L. plant1,3

What is
Sativex?
Image
test img
Image
img
Each 100μl spray contains:

2.7mg

THC¹

THC acts upon neurons
throughout the body to help regulate
synaptic activity1,4,5

2.5mg

CBD¹

CBD may counteract some
of the negative psychological effects
associated  with THC6,7

See how Sativex can give MS spasticity patients much-needed symptom relief3–10